Background -Biomarkers from routine complete blood count are known predictive factors of long-term outcomes in cancer patients. The value of these biomarkers in the setting of trimodal therapy for esophageal cancer in predicting early postoperative outcomes is not studied. Objective -The present study evaluated the value of cellular blood components changes during neoadjuvant chemoradiotherapy followed by curative intent esophagectomy for cancer in predicting postoperative mortality and morbidity. Methods -A cohort of 149 consecutive patients that underwent chemoradiotherapy using platinum-and taxane-based regimens followed by esophagectomy was analyzed. Cellular components of blood collected before neoadjuvant therapy (period A) and before surgery (period B) were assessed for postoperative mortality and complications. Univariate and multivariate Cox regression models were applied to evaluate the independent prognostic significance of blood count variables. Results -Postoperative morbidity was present in 46% of the patients. On multiple regression analysis platelet volume (B) (OR: 1.53; 95% CI: 1.2-2.33) was an independent predictor of general complications. Severe postoperative surgical complications were present in 17% of the patients. On multiple regression analysis, lymphocyte decrease between B-A periods (OR: 0.992; 95% CI: 0.990-0.997) was related to higher risk for severe complications. Cervical anastomotic leakage was present in 25.6% of the patients. On univariate analysis eosinophil count in A and B periods was related to cervical anastomotic leakage. For this outcome, multivariate joint model could not identify independent risk variables of cellular components of blood. The 30-day mortality rate was 7.4%. On univariate analysis, platelet count in period B was associated to higher risk for mortality. The multivariate joint model could not accurately predict mortality due to the few number of patients in the mortality group. Conclusion -This is the first study to assess the relationship between peripheral blood count variables changes during neoadjuvant chemoradiotherapy using a platinum-and taxane-based regimen followed by curative intent esophagectomy for cancer in predicting postoperative complications. The platelet volume prior to surgery is related to postoperative complications and the lymphocyte count change prior to surgery predicts severe postoperative complications in the setting of trimodal therapy for esophageal cancer.
INTRODUCTION
Esophageal cancer treatment is based on neoadjuvant chemoradiotherapy followed by surgery in most potentially curable esophageal cancer (1, 2) . Esophagectomy usually presents high postoperative morbidity and mortality, and certain complications may even influence long-term survival (3) .
Accumulating evidence shows that preoperative hematological biomarkers from routine complete blood count, such as red cell distribution width (RDW), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and mean corpuscular volume (MCV) may predict long-term outcomes in cancer (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . For esophageal cancer, preoperative NLR before surgery predicts overall survival (OS) and disease-free survival (DFS) (15) . Postoperative NLR elevation after surgery may also predict early postoperative outcomes in esophageal cancer (16) .
The value of cellular blood components prior to neoadjuvant therapy and prior to surgery in the setting of trimodal therapy for esophageal cancer in predicting early postoperative complications and mortality has not been reported, and is the aim of this study.
Lymphocyte count and platelet volume predicts postoperative complications in esophagectomy for cancer: a cohort study METHODS
A retrospective cohort was performed, assessing the correlation of cellular components of blood and their changes during trimodal therapy for esophageal carcinoma with postoperative mortality and postoperative complications. Consecutive patients of a single institute with completion of neoadjuvant chemoradiotherapy using platinum-and taxane-based regimens, followed by curative intent esophagectomy, were selected. Peripheral blood was obtained in two different moments: before neoadjuvant therapy (A); and before surgery (1-7 days) (B). Blood test was not collected during acute infectious disease, neither during targeted antitumor therapy.
Recruitment included 2009 to 2019 period. Patients were staged with endoscopy, CT-scan, and PET-scan prior to neoadjuvant therapy and classified accordingly to the 8th edition of UICC staging (17) . Patients were followed with clinical evaluation, peripheral blood analysis, CT-scan and endoscopy. Complications were classified accordingly to the international consensus on standardization of data collection for complications associated The predictive model for severe complications can be expressed by the following equation = exp (-1.12-0.001 x Lymphocyte (B-A) -1.47 (if thoracoscopy)) / (1+exp (-1.12-0.001 x Lymphocyte (B-A) -1.47 (if thoracoscopy)).
Cervical anastomotic leakage
Cervical anastomotic leakage was present in 25.6% of the patients, and mostly was easily manageable and classified as grade (18) I or II (90%).
On univariate analysis grade of cellular differentiation was related to cervical anastomotic leakage. Eosinophil count in A (OR: 1.001; 95% CI: 1-1.002; P=0.011), and B (OR: 1.001; 95% CI: 0.999-1.002; P=0.038) periods was also related to cervical anastomotic leakage (TABLE 3) . The multivariate joint model was performed and the risk for cervical anastomotic leakage was constant, independently of the blood cellular variables.
Postoperative mortality
The 30-day mortality rate was 7.4%. On univariate analysis, age, histology, clinical stage, Ryan pathological response score, and complications were related to 30-days postoperartive mortality. For cellular components of blood, all variables were not related to postoperartive mortality, but platelet count in period B (OR: 1.007; 95% CI: 0.999-1.017; P=0.017) (TABLE 4) . The multivariate joint model could not accurately predict postoperative 30-day mortality due to the few number of patients in the mortality group.
DISCUSSION
Results of this cohort of 149 consecutive esophageal cancer patients that underwent neoadjuvant chemoradiotherapy using a platinum-and taxane-based regimen followed by curative intent esophagectomy suggest that mean platelet volume and lymphocyte decrease during neoadjuvant therapy are independent variables that can predict postoperative complications.
It has been well established that there is a complex relationship among tumor, systemic inflammation, and nutritional and immune status (5, 11, (21) (22) (23) that may influence in surgical complications risks (24) (25) (26) .
Cancer cells release growth factors and inflammatory mediators that stimulate production and activation of peripheral blood platelets (27, 28) . Increased mean platelet volume is an early index of activated platelets (29) . In our study, mean platelet volume was related to higher risk for general complications, although the peripheral platelet count was not related to higher risk for complications.
Lymphocyte decrease in cancer patients reflects host immune function due to hormonal change, malnutrition, antitumor immune response, or may be due to chemotherapy induced depletion (30) (31) (32) (33) (34) (35) (36) . Lymphopenia has strong relationship with lower heart ejection fraction postoperatively (37) , major adverse cardiac outcomes (38) (39) (40) and infectious complications (36) . In the present study, lymphocyte decrease between B and A periods increases the risk for severe postoperative complications. Despite lymphopenia may also reflect radiation therapy side effect (41) , in the present radiation dose did not influence morbidity.
Although previous studies reported that preoperative NLR might predict severe postoperative complications for colorectal, head and neck, and gastric surgery (26, (42) (43) (44) (45) (46) , in the present study NLR and PLR were not related to postoperative complications in esophageal carcinoma. The role of eosinophils in solid tumors is unclear, and may favor an antitumor inflammatory response, depending on the surrounding stimuli (47) (48) (49) (50) . Eosinophils also might contribute to thrombophilia in patients with cancer (51, 52) . In the present study, higher eosinophil level, either prior to neoadjuvant therapy or prior to surgery, was related to higher chance of esophageal anastomotic leak on univariate analysis. The effect was not retained on multivariate analysis. This may be attributable to the small sample size of cervical anastomotic leakage.
The results of this study should be interpreted in the context of certain inherent limitations. It is a single-center retrospective study with a relatively small sample size. The low number of complication events and mortality limited the statistical power of the analysis of the results. Also, cellular blood components levels are dynamic and may vary in the same patient from day-to-day. Future controlled prospective studies are warranted to validate the predictive risk models.
Despite these limitations, this is the first study to assess the relationship between peripheral blood count variables changes during neoadjuvant chemoradiotherapy using a platinum-and taxane-based regimen followed by curative intent esophagectomy for esophageal cancer in predicting postoperative complications. Variables of routine blood count are already in use as part of the patient's routine laboratory work for esophageal cancer patients, and are easily assessable, cost-effective, readily available, and can be used as predictive risk factors for postoperative outcomes.
CONCLUSION
The platelet volume prior to surgery is related to postoperative complications and the lymphocyte count change prior to surgery predicts severe postoperative complications in the setting of trimodal therapy for esophageal cancer.
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